Xeinadin Group Limited (“Xeinadin” or “the Company”), one of the leading professional services groups in the UK and Ireland, has agreed a strategic partnership with Exponent, a private equity firm with a proven track record in professional services. This partnership will involve Exponent making a significant minority investment in Xeinadin to support the business’s ambitious growth plans. Subject to regulatory approvals, the transaction is expected to complete in Q1 2022.

Read more …